Symbols / VVOS Stock $0.59 +0.84% Vivos Therapeutics, Inc.

Healthcare • Medical Devices • United States • NCM
VVOS (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Medical Devices
CEO —
Exch · Country NCM · United States
Market Cap 8.09M
Enterprise Value —
Income —
Sales —
FCF (ttm) -9.41M
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -2.14
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand 13.71M
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) $2.42
Tgt Median $2.50
Tgt Low $1.75
Tgt High $3.00
# Analysts —
Recom —
Prev Close $0.59
Price $0.59
Change 0.84%
About

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.42
Mean price target
2. Current target
$0.59
Latest analyst target
3. DCF / Fair value
$-12.35
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.59
Low
$1.75
High
$3.00
Mean
$2.42

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-22 main Ascendiant Capital Buy → Buy $3
2026-04-17 main HC Wainwright & Co. Buy → Buy $3
2025-12-03 main Ascendiant Capital Buy → Buy $6
2025-11-17 init HC Wainwright & Co. — → Buy $7
2025-09-09 main Ascendiant Capital Buy → Buy $7
2025-04-15 main Ascendiant Capital Buy → Buy $6
2024-11-20 reit Ascendiant Capital Buy → Buy $7
2024-11-19 main Alliance Global Partners Buy → Buy $6
2024-08-20 main Ascendiant Capital Buy → Buy $7
News
RSS: Latest VVOS news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
17.44
+16.05%
15.03
+8.91%
13.80
-13.87%
16.02
Operating Revenue
17.44
+16.05%
15.03
+8.91%
13.80
-13.87%
16.02
Cost Of Revenue
6.90
+14.79%
6.01
+8.72%
5.53
-7.91%
6.00
Reconciled Cost Of Revenue
6.90
+14.79%
6.01
+8.72%
5.53
-7.91%
6.00
Gross Profit
10.54
+16.89%
9.02
+9.04%
8.27
-17.45%
10.02
Operating Expense
30.44
+50.75%
20.19
-21.03%
25.57
-27.06%
35.05
Selling General And Administration
29.13
+48.54%
19.61
-21.39%
24.95
-27.44%
34.38
Selling And Marketing Expense
1.40
-19.12%
1.73
-29.83%
2.47
-53.80%
5.34
General And Administrative Expense
27.73
+55.09%
17.88
-20.47%
22.48
-22.60%
29.04
Other Gand A
27.73
+55.09%
17.88
-20.47%
22.48
-22.60%
29.04
Total Expenses
37.34
+42.50%
26.20
-15.74%
31.10
-24.26%
41.05
Operating Income
-19.89
-78.09%
-11.17
+35.41%
-17.30
+30.90%
-25.03
Total Operating Income As Reported
-19.89
-78.09%
-11.17
+35.41%
-17.30
+30.90%
-25.03
EBITDA
-18.59
-75.50%
-10.59
+36.49%
-16.68
+31.55%
-24.36
Normalized EBITDA
-18.59
-75.50%
-10.59
+48.22%
-20.45
+20.26%
-25.65
Reconciled Depreciation
1.31
+125.30%
0.58
-6.44%
0.62
-7.17%
0.67
EBIT
-19.89
-78.09%
-11.17
+35.41%
-17.30
+30.90%
-25.03
Total Unusual Items
—
—
3.78
+193.55%
1.29
Total Unusual Items Excluding Goodwill
—
—
3.78
+193.55%
1.29
Special Income Charges
—
—
0.00
-100.00%
1.29
Other Special Charges
—
—
—
-1.29
Write Off
—
—
—
0.00
Net Income
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Pretax Income
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Net Non Operating Interest Income Expense
—
—
—
0.00
Interest Expense Non Operating
—
—
—
0.00
Net Interest Income
—
—
—
0.00
Interest Expense
—
—
—
0.00
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
-1.34
-3917.14%
0.04
-99.06%
3.71
+213.07%
1.19
Other Non Operating Income Expenses
-1.34
-3917.14%
0.04
+153.85%
-0.07
+35.64%
-0.10
Gain On Sale Of Security
—
—
3.78
—
Tax Provision
—
—
—
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Net Income From Continuing Operation Net Minority Interest
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Net Income From Continuing And Discontinued Operation
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Net Income Continuous Operations
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Normalized Income
-21.23
-90.64%
-11.14
+35.86%
-17.36
+30.92%
-25.13
Net Income Common Stockholders
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Otherunder Preferred Stock Dividend
—
—
—
—
Diluted EPS
—
-2.22
+80.07%
-11.14
+56.99%
-25.90
Basic EPS
—
-2.22
+80.07%
-11.14
+56.99%
-25.90
Basic Average Shares
—
5.02
+311.67%
1.22
+32.46%
0.92
Diluted Average Shares
—
5.02
+311.67%
1.22
+32.46%
0.92
Diluted NI Availto Com Stockholders
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Depreciation Amortization Depletion Income Statement
1.31
+125.30%
0.58
-6.44%
0.62
-7.17%
0.67
Depreciation And Amortization In Income Statement
1.31
+125.30%
0.58
-6.44%
0.62
-7.17%
0.67
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
25.15
+64.56%
15.28
+42.44%
10.73
-21.79%
13.72
Current Assets
4.38
-41.34%
7.47
+203.66%
2.46
-54.63%
5.42
Cash Cash Equivalents And Short Term Investments
2.03
-67.59%
6.26
+281.01%
1.64
-53.31%
3.52
Cash And Cash Equivalents
2.03
-67.59%
6.26
+281.01%
1.64
-53.31%
3.52
Receivables
1.58
+267.67%
0.43
+112.87%
0.20
-55.80%
0.46
Accounts Receivable
1.58
+267.67%
0.43
+112.87%
0.20
-55.80%
0.46
Gross Accounts Receivable
2.46
+200.37%
0.82
+74.47%
0.47
-59.79%
1.17
Allowance For Doubtful Accounts Receivable
-0.88
-126.15%
-0.39
-45.52%
-0.27
+62.36%
-0.71
Other Receivables
—
—
—
—
Prepaid Assets
—
—
—
—
Other Current Assets
0.77
-1.15%
0.78
+27.11%
0.62
-57.46%
1.45
Total Non Current Assets
20.77
+165.88%
7.81
-5.54%
8.27
-0.33%
8.30
Net PPE
7.92
+82.43%
4.34
-7.58%
4.70
-1.63%
4.78
Gross PPE
10.86
+52.45%
7.12
+1.40%
7.03
+7.58%
6.53
Accumulated Depreciation
-2.94
-5.61%
-2.78
-19.52%
-2.33
-32.69%
-1.75
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
3.09
+129.06%
1.35
+2.12%
1.32
+4.43%
1.26
Construction In Progress
0.00
-100.00%
1.86
+29.41%
1.44
+51.37%
0.95
Other Properties
4.57
+217.94%
1.44
-19.66%
1.79
-2.61%
1.84
Leases
3.20
+28.96%
2.48
+0.00%
2.48
+0.00%
2.48
Goodwill And Other Intangible Assets
12.62
+287.98%
3.25
-0.34%
3.26
+3.75%
3.15
Goodwill
8.57
+201.51%
2.84
+0.00%
2.84
+0.00%
2.84
Other Intangible Assets
4.04
+889.00%
0.41
-2.62%
0.42
+39.07%
0.30
Non Current Prepaid Assets
—
—
—
0.37
Other Non Current Assets
0.23
+5.56%
0.22
-29.64%
0.31
-17.91%
0.37
Total Liabilities Net Minority Interest
26.70
+264.28%
7.33
-28.97%
10.32
+15.70%
8.92
Current Liabilities
18.08
+263.12%
4.98
-31.71%
7.29
+6.99%
6.81
Payables And Accrued Expenses
7.67
+130.10%
3.33
-25.61%
4.48
+34.79%
3.32
Payables
2.48
+56.93%
1.58
-36.12%
2.47
+75.19%
1.41
Accounts Payable
1.68
+52.91%
1.10
-48.81%
2.15
+52.02%
1.41
Current Accrued Expenses
5.19
+196.01%
1.75
-12.66%
2.01
+4.97%
1.91
Employee Benefits
2.90
+138.03%
1.22
+0.00%
1.22
0.00
Total Tax Payable
0.80
+66.11%
0.48
+47.09%
0.33
—
Current Debt And Capital Lease Obligation
9.08
+1803.56%
0.48
+0.63%
0.47
+13.13%
0.42
Current Debt
8.35
—
—
—
Other Current Borrowings
8.35
—
—
—
Current Capital Lease Obligation
0.73
+52.41%
0.48
+0.63%
0.47
+13.13%
0.42
Current Deferred Liabilities
0.48
-46.54%
0.90
-58.09%
2.14
-26.93%
2.93
Current Deferred Revenue
0.48
-46.54%
0.90
-58.09%
2.14
-26.93%
2.93
Other Current Liabilities
0.85
+211.36%
0.27
+37.88%
0.20
+36.55%
0.14
Total Non Current Liabilities Net Minority Interest
8.63
+266.75%
2.35
-22.38%
3.03
+43.87%
2.11
Long Term Debt And Capital Lease Obligation
4.42
+327.25%
1.03
-31.95%
1.52
-23.72%
1.99
Long Term Debt
0.47
—
—
—
Long Term Capital Lease Obligation
3.95
+281.93%
1.03
-31.95%
1.52
-23.72%
1.99
Non Current Deferred Liabilities
0.00
-100.00%
0.10
-66.44%
0.29
+158.04%
0.11
Non Current Deferred Revenue
0.00
-100.00%
0.10
-66.44%
0.29
+158.04%
0.11
Other Non Current Liabilities
1.30
—
—
—
Stockholders Equity
-1.49
-118.73%
7.95
+1835.28%
0.41
-91.44%
4.80
Common Stock Equity
-1.49
-118.73%
7.95
+1835.28%
0.41
-91.44%
4.80
Capital Stock
0.00
0.00
0.00
0.00
Common Stock
0.00
0.00
0.00
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
9.29
+57.68%
5.89
+221.15%
1.83
+99.23%
0.92
Ordinary Shares Number
9.29
+57.68%
5.89
+221.15%
1.83
+99.23%
0.92
Additional Paid In Capital
123.87
+10.46%
112.14
+19.99%
93.46
+10.91%
84.27
Retained Earnings
-125.36
-20.32%
-104.19
-11.97%
-93.05
-17.09%
-79.47
Minority Interest
-0.06
0.00
—
—
Total Equity Gross Minority Interest
-1.55
-119.49%
7.95
+1835.28%
0.41
-91.44%
4.80
Total Capitalization
-1.02
-112.84%
7.95
+1835.28%
0.41
-91.44%
4.80
Working Capital
-13.69
-648.78%
2.50
+151.68%
-4.83
-247.59%
-1.39
Invested Capital
7.33
-7.82%
7.95
+1835.28%
0.41
-91.44%
4.80
Total Debt
13.50
+792.99%
1.51
-24.21%
2.00
-17.32%
2.41
Net Debt
6.79
—
—
—
Capital Lease Obligations
4.68
+209.52%
1.51
-24.21%
2.00
-17.32%
2.41
Net Tangible Assets
-14.11
-400.02%
4.70
+264.87%
-2.85
-272.22%
1.66
Tangible Book Value
-14.11
-400.02%
4.70
+264.87%
-2.85
-272.22%
1.66
Dueto Related Parties Current
—
—
—
—
Interest Payable
1.95
0.00
—
—
Non Current Note Receivables
—
—
—
—
Notes Receivable
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-15.26
-20.27%
-12.69
-6.24%
-11.95
+39.01%
-19.59
Cash Flow From Continuing Operating Activities
-15.26
-20.27%
-12.69
-6.24%
-11.95
+39.01%
-19.59
Net Income From Continuing Operations
-21.23
-90.64%
-11.14
+18.02%
-13.58
+43.04%
-23.84
Depreciation Amortization Depletion
1.31
+125.30%
0.58
-6.44%
0.62
-7.17%
0.67
Depreciation And Amortization
1.31
+125.30%
0.58
-6.44%
0.62
-7.17%
0.67
Other Non Cash Items
—
0.01
-87.36%
0.09
—
Stock Based Compensation
0.66
-13.25%
0.76
-31.10%
1.11
-53.84%
2.40
Asset Impairment Charge
—
—
—
0.00
Operating Gains Losses
—
0.03
+101.02%
-3.04
-487.07%
-0.52
Gain Loss On Investment Securities
—
0.03
+101.02%
-3.04
-527.71%
0.71
Change In Working Capital
4.00
+235.95%
-2.94
-202.65%
2.86
+67.39%
1.71
Change In Receivables
-0.22
+4.82%
-0.23
-189.41%
0.26
-65.82%
0.75
Changes In Account Receivables
-0.22
+4.82%
-0.23
-189.41%
0.26
-65.82%
0.75
Change In Prepaid Assets
0.05
+177.42%
-0.06
-106.80%
0.91
+729.09%
0.11
Change In Payables And Accrued Expense
4.14
+481.05%
-1.09
-194.03%
1.16
+356.89%
-0.45
Change In Accrued Expense
3.62
+9376.92%
-0.04
-109.24%
0.42
+144.85%
-0.94
Change In Payable
0.52
+150.00%
-1.05
-242.78%
0.73
+49.49%
0.49
Change In Account Payable
0.52
+150.00%
-1.05
-242.78%
0.73
+49.49%
0.49
Change In Other Working Capital
-0.51
+64.16%
-1.43
-134.70%
-0.61
-152.95%
1.15
Change In Other Current Liabilities
0.54
+517.05%
-0.13
-111.20%
1.15
+662.91%
0.15
Investing Cash Flow
-7.53
-1225.00%
-0.57
+33.41%
-0.85
+7.68%
-0.92
Cash Flow From Continuing Investing Activities
-7.53
-1225.00%
-0.57
+33.41%
-0.85
+7.68%
-0.92
Net PPE Purchase And Sale
-2.34
-312.15%
-0.57
+29.27%
-0.80
+13.10%
-0.92
Purchase Of PPE
-2.34
-312.15%
-0.57
+29.27%
-0.80
+13.10%
-0.92
Capital Expenditure
-2.34
-312.15%
-0.57
+29.27%
-0.80
+13.10%
-0.92
Net Business Purchase And Sale
-5.18
0.00
—
0.00
Purchase Of Business
-5.18
0.00
—
0.00
Net Other Investing Changes
—
—
-0.05
—
Financing Cash Flow
18.56
+3.82%
17.88
+63.65%
10.92
0.00
Cash Flow From Continuing Financing Activities
18.56
+3.82%
17.88
+63.65%
10.92
0.00
Net Issuance Payments Of Debt
10.64
0.00
—
0.00
Issuance Of Debt
10.67
0.00
—
—
Repayment Of Debt
-0.03
0.00
—
0.00
Long Term Debt Issuance
10.67
0.00
—
—
Long Term Debt Payments
-0.03
0.00
—
0.00
Net Long Term Debt Issuance
10.64
0.00
—
0.00
Net Common Stock Issuance
5.58
-28.48%
7.80
+94.90%
4.00
0.00
Repurchase Of Capital Stock
—
—
—
0.00
Proceeds From Stock Option Exercised
3.17
-72.26%
11.44
+43.01%
8.00
—
Net Other Financing Charges
-0.84
+38.50%
-1.36
-26.37%
-1.08
—
Changes In Cash
-4.23
-191.64%
4.62
+346.11%
-1.88
+90.85%
-20.51
Beginning Cash Position
6.26
+281.01%
1.64
-53.31%
3.52
-85.36%
24.03
End Cash Position
2.03
-67.59%
6.26
+281.01%
1.64
-53.31%
3.52
Free Cash Flow
-17.60
-32.77%
-13.26
-4.00%
-12.75
+37.84%
-20.51
Interest Paid Supplemental Data
0.00
-100.00%
0.01
0.00
0.00
Income Tax Paid Supplemental Data
—
—
—
—
Common Stock Issuance
5.58
-28.48%
7.80
+94.90%
4.00
0.00
Issuance Of Capital Stock
5.58
-28.48%
7.80
+94.90%
4.00
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
—
Preferred Stock Payments
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category